Aebi Schmidt Holding AG financials

AEBI CIK 0002048519

Source: EDGAR filings · Built 2026-06-02T02:14:57Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2025FY 2025
Free Cash Flow -6.56M 54.26M 17.31M
EBITDA 117.27M 94.91M 86.20M
Working Capital 416.48M 250.94M
Net Debt 662.06M 398.67M
Gross Margin 19.92% 21.02% 20.35%
Operating Margin 4.79% 6.31% 5.81%
Net Margin 0.64% 2.83% 1.10%
Return on Equity (ROE) 1.20% 8.40% 3.31%
Return on Assets (ROA) 0.48% 2.82%
Current Ratio 1.90× 1.94×
Debt-to-Equity 0.93× 1.27×
Effective Tax Rate 13.28% 26.23% 35.44%
Cash Conversion Ratio 0.92× 2.24× 2.69×
Accruals Ratio 0.00× -0.04×
SBC % of Revenue 0.47% 0.00% 0.00%
CapEx Coverage 0.58× 4.74× 2.36×
Free Cash Flow Per Share $-0.11 $1.34 $0.43

Valuation Metrics

Concept FY 2025FY 2025FY 2025
P/E Trailing (Diluted) 74.41×
EV / EBITDA 13.95×
P/S 0.64×
P/B 1.20×

Income Statement

Concept FY 2025FY 2025FY 2025
Revenue from Contract with Customer, Excluding Assessed Tax 1.53B 1.09B 1.02B
Cost of Goods and Services Sold 1.22B 857.72M 808.92M
Gross Profit 304.05M 228.24M 206.65M
Research and Development Expense 26.49M 19.56M 17.13M
Selling, General and Administrative Expense 180.65M 124.66M 117.06M
Operating Expenses 230.99M 159.75M 147.62M
Operating Income (Loss) 73.07M 68.49M 59.03M
Income Tax Expense (Benefit) 1.49M 10.93M 6.15M
Net Income (Loss) Attributable to Parent 9.74M 30.68M 11.20M
Earnings Per Share, Basic $0.17 $0.76 $0.28
Weighted Average Number of Shares Outstanding, Basic 58.66M 40.36M 40.34M
Earnings Per Share, Diluted $0.17 $0.76 $0.28
Weighted Average Number of Shares Outstanding, Diluted 58.78M 40.36M 40.34M

Balance Sheet

Concept FY 2025FY 2025FY 2025
Cash and Cash Equivalents, at Carrying Value 98.51M 65.17M
Assets, Current 877.73M 518.16M
Assets 2.01B 1.09B
Long-term Debt 594.96M 399.85M
Liabilities, Current 461.25M 267.22M
Long-term Debt, Excluding Current Maturities 548.05M 376.59M
Liabilities 1.19B 722.95M
Stockholders' Equity Attributable to Parent 814.90M 365.09M
Common Stock, Shares, Outstanding 77.00M 40.35M

Cash Flow Statement

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (AEBI CIK 0002048519), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

TRST

TRUSTCO BANK CORP NY

CRNC

CERENCE INC.

MD

Pediatrix Medical Group, Inc.